Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.
about
Clostridium difficile toxins: mechanism of action and role in disease.Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficileThe Role of Rho GTPases in Toxicity of Clostridium difficile ToxinsDiversity and Evolution in the Genome of Clostridium difficileNew types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from AsiaTruncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin AAnalysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of JapanEvaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification.Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infectionsCharacterization of a stable, metronidazole-resistant Clostridium difficile clinical isolateImpacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children.Clostridium difficile testing: after 20 years, still challenging.Clostridium difficile-associated colitisSensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules.Clostridium difficile: an emerging pathogen in children.Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaksCharacterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One RegionOpen-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.Genotypic investigation of Clostridium difficile in Prince Edward Island.Microarray identification of Clostridium difficile core components and divergent regions associated with host origin.Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.The host immune response to Clostridium difficile infectionImmunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model.Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in FranceSix rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.Recent emergence of an epidemic clindamycin-resistant clone of Clostridium difficile among Polish patients with C. difficile-associated diarrhea.Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins.Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.Both, toxin A and toxin B, are important in Clostridium difficile infection.Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea.Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types.Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.
P2860
Q24522454-2450AB32-B343-471F-933E-17574B5A109BQ24642390-74A0B00D-B00D-4A04-AEA4-9C17CAB561BCQ26775010-BF75BC24-6507-4D98-B225-4C4983CC1C55Q28084700-6324AF36-4983-45A4-919D-19E20145F3FAQ31134424-0466BD74-D27B-4583-8B33-06FE6A25C4B9Q33475206-047CD87C-3F5B-43DE-8107-D97F341053A2Q33971904-F86B042B-E718-4B98-B38E-345302C7787CQ33973121-BFD512BE-4CE7-436E-9052-24313956F90FQ34146714-BE7CCE01-25D3-4DE8-B94D-36DB51996860Q34231705-80828DE6-A839-4B74-99E8-556B0E8BF095Q34263649-EB541A20-CE7F-4D1C-88C5-696273C4E074Q34562315-FCABA6FF-C10D-4403-9370-CD5F33AEDC9FQ34698807-9D1EA42C-03DA-4577-9B65-D3A695ACE45FQ35062641-38A750BB-B92A-4940-8757-32E53988FFC3Q35983360-50539C7A-20A6-4DE3-B702-5326935F3C45Q36155874-90267474-1A70-4C1A-8735-D6A94C0D9C63Q36533541-763FE406-4C18-4716-AA2C-C02CF24B3805Q36898358-F0F9AD54-BA15-439D-8935-7345DEAAAB87Q36970016-40DB076F-3B0F-4721-9D59-EED41DD1816AQ36996846-56B46357-76A1-4434-8067-6806ECF7C985Q37067252-22C933F0-82FE-4DFF-8909-6FEA4E620AD5Q37145737-19E97645-8D4C-4316-8E17-DC980655C5C6Q37232515-6046CF9F-937E-4E79-AFF8-36D71D9A0C3CQ37669796-A853735A-FD44-49B6-BBEB-8B90D16C04ECQ38244134-8B49E9DA-CF35-42D8-9E6D-50BBE00049ABQ38633032-0AFC56DA-D634-4F42-995A-4ABC357987F5Q39422769-F832F6C7-BFA9-4CDE-9C1C-627A7A5FF2E7Q39664770-C9A4A434-D8B5-4392-A0BF-17C1072F3EFFQ39733115-20CC7B0F-A1E7-4090-8166-FB32DC10367CQ39748439-23B8E9C2-EB96-4F78-9D7D-CBCF3A8F047AQ39887293-7E1A0B9E-1C4C-43B3-86DE-22DA6F797163Q39978401-957C7C1F-A438-4E95-85DE-CD596F445364Q40173019-802FF7D5-0E51-4B25-A2B3-E9A0F6861E1AQ40179427-2C85A869-2F3E-47A2-89D0-635A4F04929EQ40478915-E5B3F0BD-C498-43CE-BF3B-2A8B561F1337Q40625108-68BF4CA7-37C9-4505-9EEB-065E4D6F4EE7Q40638584-F18402D6-4FD5-4B56-A2C3-24EBCC1F0FFEQ40770963-E4BFF3A6-4938-4B56-A2FB-FB6338072536Q40938187-2CCF95CB-4AD3-4205-BAC0-6824AC0E5CC8Q42546219-9C5333E9-D45D-420E-8CED-27444BE9ECD2
P2860
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of a toxin A- ...... difficile-associated diarrhea.
@ast
Characterization of a toxin A- ...... difficile-associated diarrhea.
@en
type
label
Characterization of a toxin A- ...... difficile-associated diarrhea.
@ast
Characterization of a toxin A- ...... difficile-associated diarrhea.
@en
prefLabel
Characterization of a toxin A- ...... difficile-associated diarrhea.
@ast
Characterization of a toxin A- ...... difficile-associated diarrhea.
@en
P2093
P2860
P1476
Characterization of a toxin A- ...... difficile-associated diarrhea
@en
P2093
A Al-Barrak
G K Harding
L M Neville
S Moncrief
P2860
P304
P407
P577
2000-07-01T00:00:00Z